bibliographicCitation |
Van Gaal L, Pi-Sunyer X, Després JP, McCarthy C, Scheen A. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care. 2008 Feb;31 Suppl 2():S229–40. doi: 10.2337/dc08-s258. PMID: 18227491. |